tiprankstipranks
Trending News
More News >
dentalcorp Holdings (TSE:DNTL)
TSX:DNTL

dentalcorp Holdings (DNTL) AI Stock Analysis

Compare
120 Followers

Top Page

TSE:DNTL

dentalcorp Holdings

(TSX:DNTL)

Select Model
Select Model
Select Model
Neutral 63 (OpenAI - 4o)
Rating:63Neutral
Price Target:
C$11.50
▲(5.41% Upside)
The overall stock score for dentalcorp Holdings is primarily influenced by its financial performance and technical analysis. While the company shows positive revenue and cash flow growth, it struggles with profitability, impacting its valuation. Technical indicators suggest a neutral to slightly bullish outlook, but the negative P/E ratio remains a concern. The absence of earnings call data and corporate events means these factors do not influence the score.
Positive Factors
Revenue Growth
Consistent revenue growth indicates strong market demand and effective business operations, supporting long-term sustainability.
Cash Flow Generation
Robust cash flow generation enhances financial flexibility, enabling investment in growth opportunities and debt management.
Stable Gross Margins
Stable margins reflect efficient cost management, which is crucial for maintaining profitability as the company scales.
Negative Factors
Profitability Challenges
Ongoing profitability issues can hinder long-term growth and investor confidence, necessitating strategic improvements.
Negative Return on Equity
Negative ROE indicates inefficiencies in generating shareholder returns, potentially impacting investor appeal and capital raising.
Negative Net Profit Margin
A negative profit margin suggests ongoing cost pressures or revenue challenges, which could affect long-term financial health.

dentalcorp Holdings (DNTL) vs. iShares MSCI Canada ETF (EWC)

dentalcorp Holdings Business Overview & Revenue Model

Company DescriptionDentalcorp Holdings (DNTL) is a leading dental service organization based in Canada that partners with dental practices to enhance operational efficiency and patient care. The company focuses on providing a comprehensive range of dental services, including general dentistry, orthodontics, and specialty care, while supporting its affiliated practices with management services, marketing, and technology solutions. Dentalcorp aims to improve the delivery of dental care through innovation and collaboration, positioning itself as a key player in the dental healthcare sector.
How the Company Makes MoneyDentalcorp generates revenue primarily through a service model that involves partnerships with dental practices. The company earns money by charging management fees to its affiliated dental clinics for various support services, including practice management, human resources, marketing, and procurement. Additionally, Dentalcorp may receive a percentage of the revenue generated by these clinics as part of their partnership agreements. Key revenue streams include patient care services, operational support, and potentially franchise-like fees from practices adopting its systems. Significant partnerships with dental supply companies and technology providers may also enhance its service offerings and revenue potential.

dentalcorp Holdings Earnings Call Summary

Earnings Call Date:Nov 12, 2024
(Q3-2024)
|
% Change Since: |
Next Earnings Date:Mar 20, 2026
Earnings Call Sentiment Positive
The earnings call reflected a strong financial performance with significant growth in revenue, EBITDA, and free cash flow conversion. Strategic acquisitions and partnerships, particularly in AI technology, bolster future growth prospects. However, there are potential challenges with the continued rollout of the CDCP and interest rate expenses. Overall, the sentiment is positive due to the outweighing highlights.
Q3-2024 Updates
Positive Updates
Strong Revenue and EBITDA Growth
Revenue for Q3 2024 was $375.4 million, up 11.4% from Q3 2023. Adjusted EBITDA was $68.9 million, an increase of 13.1% over the same period.
Improved Free Cash Flow Conversion
Free cash flow conversion improved to 63% on an LTM basis, up from 58% in Q3 2023.
Successful M&A Activity
Acquired 4 practices for $16 million, expected to generate $2.3 million in pro forma adjusted EBITDA. Completed 9 acquisitions post-quarter-end, reaching the annual target of $20 million in acquired EBITDA.
Strategic Partnerships and Innovations
Formed a strategic partnership with VideaHealth to deploy AI technology across the network, enhancing clinical excellence and business efficiencies.
Deleveraging Efforts
Net leverage reduced to 4.0x, down 0.4x from the previous year, marking the fourth consecutive quarter of deleveraging.
Positive Outlook for Q4 2024
Anticipated revenue growth of 8% to 10% over Q4 2023, with adjusted EBITDA margins expected to increase by 20 basis points.
Negative Updates
Potential Disruption from CDCP Rollout
Uncertainty regarding the timing of the CDCP expansion to 18-64 age group could cause disruptions similar to the initial rollout in early 2024.
Interest Rate Challenges
Interest rate ceiling of 6% through January 2028, though improved from 6.6%, still represents a significant expense.
Company Guidance
During the Dentalcorp Q3 2024 earnings call, the company provided guidance indicating a robust financial performance with several key metrics. Dentalcorp reported a revenue of $375.4 million for the third quarter, marking an 11.4% increase from the same period in 2023. Adjusted EBITDA rose to $68.9 million, reflecting a 13.1% growth, while EBITDA margins improved by 30 basis points to 18.4%. The company also highlighted a same practice revenue growth of 4.2% for the quarter and achieved a free cash flow per share of $0.19, up by 36.4% year-over-year. They completed acquisitions adding $8.5 million in pro forma adjusted EBITDA after rent, bringing them close to their annual target of $20 million. Looking forward, Dentalcorp expects an 8% to 10% revenue increase in Q4 2024, with adjusted EBITDA margins projected to rise by 20 basis points compared to Q4 2023. Additionally, free cash flow conversion improved to 63% on an LTM basis, up from 58% in Q3 2023, with net leverage reduced to 4.0x, continuing a trend of deleveraging for the fourth consecutive quarter.

dentalcorp Holdings Financial Statement Overview

Summary
dentalcorp Holdings is experiencing steady revenue growth and has a solid cash flow position, which are positive indicators for future performance. However, the company faces challenges in profitability, as evidenced by negative net income and return on equity. The balance sheet is stable, with a manageable level of debt. To improve its financial standing, the company should focus on enhancing profitability while maintaining its growth trajectory.
Income Statement
65
Positive
dentalcorp Holdings has shown a consistent revenue growth trend, with a TTM revenue growth rate of 2.24%. However, the company is struggling with profitability, as indicated by a negative net profit margin of -3.66% and a modest EBIT margin of 1.12%. The gross profit margin is relatively healthy at 46.28%, suggesting efficient cost management. Overall, while revenue is growing, the company needs to improve its profitability metrics.
Balance Sheet
60
Neutral
The balance sheet shows a moderate debt-to-equity ratio of 0.78, indicating a balanced approach to leveraging. However, the return on equity is negative at -3.31%, reflecting challenges in generating returns for shareholders. The equity ratio stands at 51.63%, suggesting a stable capital structure. The company needs to focus on improving its profitability to enhance shareholder value.
Cash Flow
70
Positive
The cash flow statement reflects a positive trajectory, with a free cash flow growth rate of 9.06% in the TTM period. The operating cash flow to net income ratio is slightly above 1, indicating that the company generates sufficient cash from operations to cover its net losses. The free cash flow to net income ratio is 0.74, showing that while the company is not yet profitable, it is generating positive cash flows, which is a positive sign for future financial health.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.66B1.55B1.43B1.25B1.03B666.20M
Gross Profit790.90M772.70M493.70M611.90M495.40M321.60M
EBITDA249.30M222.20M197.40M183.40M75.10M99.70M
Net Income-27.30M-59.40M-85.60M-16.60M-160.40M-157.10M
Balance Sheet
Total Assets3.47B3.38B3.29B3.38B2.84B2.57B
Cash, Cash Equivalents and Short-Term Investments62.10M79.50M39.00M110.50M141.80M101.50M
Total Debt1.40B1.37B1.35B1.37B1.15B1.65B
Total Liabilities1.70B1.61B1.55B1.59B1.32B1.99B
Stockholders Equity1.77B1.77B1.74B1.79B1.51B584.00M
Cash Flow
Free Cash Flow177.00M147.10M123.80M106.00M36.80M-52.40M
Operating Cash Flow234.90M194.20M153.40M138.60M55.10M-35.20M
Investing Cash Flow-252.60M-170.80M-172.10M-419.80M-262.90M-151.30M
Financing Cash Flow7.70M16.50M-52.30M247.50M248.10M202.60M

dentalcorp Holdings Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price10.91
Price Trends
50DMA
10.92
Positive
100DMA
9.81
Positive
200DMA
8.99
Positive
Market Momentum
MACD
0.03
Positive
RSI
56.45
Neutral
STOCH
29.29
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:DNTL, the sentiment is Neutral. The current price of 10.91 is below the 20-day moving average (MA) of 10.95, below the 50-day MA of 10.92, and above the 200-day MA of 8.99, indicating a neutral trend. The MACD of 0.03 indicates Positive momentum. The RSI at 56.45 is Neutral, neither overbought nor oversold. The STOCH value of 29.29 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for TSE:DNTL.

dentalcorp Holdings Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
C$1.85B20.4965.57%2.26%11.59%41.99%
71
Outperform
C$278.38M2.1539.85%2.33%-40.05%558.77%
63
Neutral
C$1.98B46.877.07%4.45%11.47%6.45%
63
Neutral
C$2.18B-77.90-1.56%0.69%10.09%67.54%
59
Neutral
C$244.79M3,900.000.11%0.52%0.19%
58
Neutral
C$990.14M-22.45-5.11%26.20%-156.86%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:DNTL
dentalcorp Holdings
10.93
2.62
31.53%
TSE:CRRX
CareRx
3.90
1.90
95.00%
TSE:EXE
Extendicare
22.07
12.21
123.83%
TSE:SIA
Sienna Senior Living
21.03
6.14
41.24%
TSE:DR
Medical Facilities
15.42
0.27
1.79%
TSE:WELL
WELL Health Technologies Corp
3.90
-3.31
-45.91%

dentalcorp Holdings Corporate Events

M&A TransactionsShareholder Meetings
Dentalcorp Securityholders Approve GTCR Acquisition
Positive
Dec 4, 2025

Dentalcorp Holdings Ltd. announced that its securityholders have approved the acquisition by investment funds affiliated with GTCR LLC. This acquisition, valued at C$11.00 per share, is expected to provide Dentalcorp with enhanced flexibility to execute its long-term strategy, invest in technology and professional development, and expand its network of dental practices. The transaction reinforces Dentalcorp’s position as a leading partner for dental practices and is anticipated to close in the first quarter of 2026, pending customary conditions and regulatory approvals.

M&A TransactionsShareholder Meetings
Dentalcorp Receives Proxy Advisor Support for GTCR Acquisition
Positive
Nov 27, 2025

Dentalcorp Holdings has announced that proxy advisory firms ISS and Glass Lewis recommend shareholders vote in favor of a proposed arrangement where GTCR LLC will acquire all of Dentalcorp’s voting shares for $11.00 per share in cash. This transaction, which excludes shares owned by key executives and partner dentists participating in a rollover opportunity, is supported by the company’s board and a special committee, highlighting its fairness and alignment with the company’s best interests.

M&A TransactionsFinancial Disclosures
Dentalcorp Holdings Reports Strong Q3 2025 Results and Announces Acquisition Agreement
Positive
Nov 6, 2025

Dentalcorp Holdings reported a strong financial performance in the third quarter of 2025, with revenue increasing by 11.9% to $420.1 million and adjusted EBITDA rising by 14.2% compared to the previous year. The company expanded its operations by acquiring 13 new practice locations, contributing to a total of 590 locations, and achieved a high recurring patient visit rate of 90.3%. Additionally, Dentalcorp announced an arrangement agreement to be acquired by funds affiliated with GTCR LLC in an all-cash transaction valued at approximately $2.2 billion on an equity value basis. This acquisition, offering a 33% premium on the share price, signifies a significant shift in the company’s ownership structure and market positioning.

M&A TransactionsShareholder Meetings
Dentalcorp Secures Interim Order for GTCR Acquisition
Positive
Nov 4, 2025

Dentalcorp Holdings Ltd. has received an interim order from the Supreme Court of British Columbia for a special meeting regarding its acquisition by GTCR-affiliated funds. The arrangement involves a cash offer of C$11.00 per share, a 33% premium on the 20-day VWAP. L Catterton Investor will receive cash for its shares, aligning with other shareholders, and has amended its voting support agreement to favor the acquisition. The transaction has significant backing from key stakeholders, representing a 60.8% voting interest, and the Board recommends approval.

M&A TransactionsBusiness Operations and Strategy
Dentalcorp to be Acquired by GTCR in C$2.2 Billion Deal
Positive
Sep 26, 2025

Dentalcorp Holdings Ltd. has agreed to be acquired by investment funds affiliated with GTCR in an all-cash transaction valued at approximately C$2.2 billion. This acquisition offers a 33% premium to the 20-day VWAP of Dentalcorp’s shares and has received support from shareholders representing 60.8% of the voting interest. The transaction, unanimously approved by Dentalcorp’s board, is expected to provide enhanced flexibility for the company to execute its long-term strategy, invest in technology, and expand its network of dental practices across Canada. GTCR’s experience in healthcare services is anticipated to support Dentalcorp’s growth and maintain its position as a leader in Canadian dentistry.

DividendsFinancial Disclosures
Dentalcorp Declares Dividend and Sets Date for Q3 2025 Results
Positive
Sep 19, 2025

Dentalcorp Holdings Ltd., a leading network of dental practices in Canada and North America, has announced a dividend of $0.025 per share for its Subordinate and Multiple Voting Shares, payable on October 21, 2025, to shareholders of record as of October 2, 2025. Additionally, the company will release its third-quarter 2025 financial results on November 6, 2025, before the market opens, followed by a conference call to provide a business update. This announcement highlights Dentalcorp’s commitment to rewarding its shareholders and maintaining transparency in its financial performance.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 19, 2025